Variant report

Variant	nsv968011
Chromosome Location	chr4:143325315-143333139
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ATF3	chr4:143329015-143329429	A549	lung:	n/a	n/a
2	ATF3	chr4:143328695-143329751	HCT-116	colon:	n/a	n/a
3	ATF3	chr4:143329103-143329732	A549	lung:	n/a	n/a
4	BCL11A	chr4:143326597-143326837	GM12878	blood:	n/a	n/a
5	BCL11A	chr4:143326567-143326904	GM12878	blood:	n/a	n/a
6	BCL3	chr4:143328888-143329606	A549	lung:	n/a	chr4:143329213-143329222 chr4:143329212-143329221
7	BCL3	chr4:143329035-143329532	A549	lung:	n/a	chr4:143329213-143329222 chr4:143329212-143329221
8	BHLHE40	chr4:143326298-143326786	A549	lung:	n/a	chr4:143326645-143326654 chr4:143326646-143326655 chr4:143326646-143326655
9	BHLHE40	chr4:143326537-143326694	HepG2	liver:	n/a	chr4:143326645-143326654 chr4:143326646-143326655 chr4:143326646-143326655
10	BHLHE40	chr4:143327366-143327784	GM12878	blood:	n/a	n/a
11	BHLHE40	chr4:143326598-143326796	K562	blood:	n/a	chr4:143326645-143326654 chr4:143326646-143326655 chr4:143326646-143326655
12	BHLHE40	chr4:143326168-143327057	GM12878	blood:	n/a	chr4:143326645-143326654 chr4:143326646-143326655 chr4:143326646-143326655
13	BHLHE40	chr4:143328472-143328566	GM12878	blood:	n/a	n/a
14	CBX3	chr4:143325211-143325787	HCT-116	colon:	n/a	n/a
15	CEBPB	chr4:143328829-143329661	A549	lung:	n/a	n/a
16	CEBPB	chr4:143326021-143327054	IMR90	lung:	n/a	chr4:143326150-143326163
17	CEBPB	chr4:143328626-143329596	HCT-116	colon:	n/a	n/a
18	CEBPB	chr4:143325934-143326453	A549	lung:	n/a	chr4:143326150-143326163
19	CEBPB	chr4:143326049-143326472	A549	lung:	n/a	chr4:143326150-143326163
20	CEBPB	chr4:143325986-143326607	ECC-1	luminal epithelium:	n/a	chr4:143326150-143326163
21	CEBPB	chr4:143328758-143329568	ECC-1	luminal epithelium:	n/a	n/a
22	CEBPB	chr4:143325202-143325942	HCT-116	colon:	n/a	chr4:143325613-143325626 chr4:143325870-143325882
23	CEBPB	chr4:143328675-143329756	A549	lung:	n/a	n/a
24	CEBPB	chr4:143328825-143329652	A549	lung:	n/a	n/a
25	CEBPB	chr4:143329129-143329580	MCF-7	breast:	n/a	n/a
26	CEBPB	chr4:143328882-143329527	IMR90	lung:	n/a	n/a
27	CEBPB	chr4:143328577-143329755	HCT-116	colon:	n/a	n/a
28	CEBPB	chr4:143328773-143329684	Hela-S3	cervix:	n/a	n/a
29	CHD1	chr4:143326321-143326848	GM12878	blood:	n/a	n/a
30	CHD2	chr4:143326300-143326980	GM12878	blood:	n/a	n/a
31	CHD2	chr4:143328801-143329781	Hela-S3	cervix:	n/a	n/a
32	CHD2	chr4:143327420-143327687	GM12878	blood:	n/a	n/a
33	CREB1	chr4:143326290-143326562	A549	lung:	n/a	n/a
34	CREB1	chr4:143329351-143329576	A549	lung:	n/a	n/a
35	CTCF	chr4:143326293-143326393	Fibrobl	skin:	n/a	n/a
36	CTCF	chr4:143326400-143326550	HCPEpiC	choroid plexus:	n/a	n/a
37	CUX1	chr4:143326501-143326650	GM12878	blood:	n/a	n/a
38	CUX1	chr4:143327569-143327661	GM12878	blood:	n/a	n/a
39	CUX1	chr4:143326899-143326944	GM12878	blood:	n/a	n/a
40	E2F4	chr4:143329032-143329322	MCF10A-Er-Src	breast:	n/a	n/a
41	E2F4	chr4:143325988-143326066	MCF10A-Er-Src	breast:	n/a	n/a
42	EBF1	chr4:143326398-143326751	GM12878	blood:	n/a	chr4:143326580-143326591
43	EBF1	chr4:143326438-143326760	GM12878	blood:	n/a	chr4:143326580-143326591
44	EBF1	chr4:143326248-143327165	GM12878	blood:	n/a	chr4:143326580-143326591 chr4:143327120-143327130
45	EBF1	chr4:143327433-143327676	GM12878	blood:	n/a	n/a
46	EP300	chr4:143326339-143327167	GM12878	blood:	n/a	chr4:143326808-143326821
47	EP300	chr4:143328928-143329772	SK-N-SH	brain:	n/a	chr4:143329212-143329221 chr4:143329213-143329222 chr4:143329415-143329429
48	EP300	chr4:143329103-143329773	ECC-1	luminal epithelium:	n/a	chr4:143329212-143329221 chr4:143329213-143329222 chr4:143329415-143329429
49	EP300	chr4:143329129-143329589	MCF-7	breast:	n/a	chr4:143329212-143329221 chr4:143329213-143329222 chr4:143329415-143329429
50	EP300	chr4:143326120-143327774	ECC-1	luminal epithelium:	n/a	chr4:143326808-143326821

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr4:143327279-143327329	HUVEC	blood vessel:	n/a
2	chr4:143327279-143327329	SK-N-SH_RA	brain:	n/a
3	chr4:143327279-143327329	GM19239	blood:	n/a
4	chr4:143326541-143326591	SK-N-MC	brain:	n/a
5	chr4:143327279-143327329	AG09309	skin:	n/a
6	chr4:143326541-143326591	SAEC	small airway:	n/a
7	chr4:143326541-143326591	AG10803	skin:	n/a
8	chr4:143326541-143326591	HEK293	kidney:	embryo
9	chr4:143326541-143326591	PrEC	prostate:	n/a
10	chr4:143326541-143326591	HIPEpiC	eye:	n/a
11	chr4:143327279-143327329	GM06990	blood:	n/a
12	chr4:143326541-143326591	HRPEpiC	eye:	n/a
13	chr4:143326541-143326591	NT2-D1	testis:	n/a
14	chr4:143327279-143327329	HCPEpiC	choroid plexus:	n/a
15	chr4:143327279-143327329	NT2-D1	testis:	n/a
16	chr4:143327279-143327329	NHDF-neo	bronchial:	n/a
17	chr4:143327279-143327329	ECC-1	luminal epithelium:	n/a
18	chr4:143326541-143326591	NHBE	bronchial:	n/a
19	chr4:143327279-143327329	Hela-S3	cervix:	n/a
20	chr4:143327279-143327329	ProgFib	skin:	n/a
21	chr4:143327279-143327329	BE2_C	brain:	n/a
22	chr4:143327279-143327329	HL-60	blood:	n/a
23	chr4:143326541-143326591	HL-60	blood:	n/a
24	chr4:143326541-143326591	MCF10A-Er-Src	breast:	n/a
25	chr4:143327279-143327329	AG10803	skin:	n/a
26	chr4:143327279-143327329	A549	lung:	n/a
27	chr4:143326541-143326591	HMEC	breast:	n/a
28	chr4:143326541-143326591	SK-N-SH_RA	brain:	n/a
29	chr4:143326541-143326591	K562	blood:	n/a
30	chr4:143327279-143327329	CMK	blood:	n/a
31	chr4:143326541-143326591	AoSMC	blood vessel:	n/a
32	chr4:143327279-143327329	PANC-1	pancreas:	n/a
33	chr4:143326541-143326591	ovcar-3	ovarian:	n/a
34	chr4:143326541-143326591	A549	lung:	n/a
35	chr4:143326541-143326591	HUVEC	blood vessel:	n/a
36	chr4:143327279-143327329	BJ	skin:	n/a
37	chr4:143327279-143327329	AG04450	lung:	fetal
38	chr4:143326541-143326591	HAEpiC	amniotic membrane:	n/a
39	chr4:143327279-143327329	IMR90	lung:	fetal
40	chr4:143327279-143327329	PrEC	prostate:	n/a
41	chr4:143327279-143327329	HCF	heart:	n/a
42	chr4:143326541-143326591	SK-N-SH	brain:	n/a
43	chr4:143327279-143327329	AG04449	skin:	fetal
44	chr4:143327279-143327329	HNPCEpiC	eye:	n/a
45	chr4:143327279-143327329	T-47D	breast:	n/a
46	chr4:143326541-143326591	Caco-2	colon:	n/a
47	chr4:143327279-143327329	RPTEC	kidney:	n/a
48	chr4:143327279-143327329	AG09319	gingival:	n/a
49	chr4:143326541-143326591	Hela-S3	cervix:	n/a
50	chr4:143327279-143327329	GM12878	blood:	n/a

No.	Distal block	Cell Line	Cell type
1	chr4:143327221..143331819-chr4:143394116..143397905,6	MCF-7	breast:
2	chr4:143326578..143329374-chr4:143334403..143336752,2	MCF-7	breast:
3	chr4:143329246..143331724-chr4:143394946..143397603,2	MCF-7	breast:
4	chr4:143323626..143325827-chr4:143327783..143329444,2	MCF-7	breast:
5	chr4:143327600..143329351-chr4:143391019..143392587,2	MCF-7	breast:
6	chr4:143325204..143328052-chr4:143329369..143331375,2	K562	blood:
7	chr4:143327592..143330271-chr4:143378912..143381553,2	MCF-7	breast:
8	chr4:143326852..143329330-chr4:143520781..143523143,2	MCF-7	breast:
9	chr4:143327412..143330052-chr4:143383937..143385936,2	MCF-7	breast:
10	chr4:143326731..143329100-chr4:143388048..143390704,2	MCF-7	breast:

Variant related genes	Relation type
INPP4B	TF binding region
INPP4B	CpG island
ENSG00000109452	chromatin interactions

Extended variants
information (count: 283 )
Associated
traits (count: 75 )

Variant overlapped rSNPs/rCNVs (count:283 , 50 per page) page: 1 2 3 4 5 6

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs577634392	chr4:143325375-143325376	Enhancers Weak transcription Active TSS Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
2	rs538314498	chr4:143325396-143325397	Enhancers Weak transcription Active TSS Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
3	rs371622352	chr4:143325398-143325399	Enhancers Weak transcription Active TSS Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
4	rs150146382	chr4:143325419-143325420	Flanking Active TSS Weak transcription Active TSS Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
5	rs550284710	chr4:143325426-143325427	Flanking Active TSS Weak transcription Active TSS Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
6	rs553475594	chr4:143325496-143325497	Flanking Active TSS Weak transcription Active TSS Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
7	rs11939457	chr4:143325564-143325565	Flanking Active TSS Weak transcription Active TSS Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
8	rs572051786	chr4:143325630-143325631	Active TSS Weak transcription Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
9	rs542512372	chr4:143325756-143325757	Active TSS Weak transcription Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
10	rs559314224	chr4:143325793-143325794	Active TSS Weak transcription Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
11	rs182719881	chr4:143325834-143325835	Active TSS Weak transcription Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
12	rs147569838	chr4:143325873-143325874	Active TSS Weak transcription Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
13	rs71586286	chr4:143325894-143325895	Active TSS Weak transcription Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
14	rs187002714	chr4:143325916-143325917	Active TSS Weak transcription Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
15	rs533872720	chr4:143325957-143325958	Active TSS Weak transcription Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
16	rs78586791	chr4:143325965-143325966	Active TSS Weak transcription Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
17	rs77982649	chr4:143325967-143325968	Active TSS Weak transcription Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
18	rs114634284	chr4:143326043-143326044	Active TSS Weak transcription Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
19	rs542926507	chr4:143326046-143326047	Active TSS Weak transcription Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
20	rs566749134	chr4:143326053-143326054	Active TSS Weak transcription Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
21	rs111429467	chr4:143326061-143326062	Active TSS Weak transcription Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
22	rs144020717	chr4:143326075-143326076	Active TSS Weak transcription Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
23	rs372673426	chr4:143326078-143326079	Active TSS Weak transcription Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
24	rs200953154	chr4:143326097-143326098	Active TSS Weak transcription Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
25	rs553319928	chr4:143326098-143326099	Active TSS Weak transcription Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
26	rs3775703	chr4:143326120-143326121	Active TSS Weak transcription Enhancers Flanking Active TSS	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
27	rs549705326	chr4:143326153-143326154	Active TSS Weak transcription Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
28	rs567920908	chr4:143326234-143326235	Active TSS Weak transcription Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
29	rs538461183	chr4:143326245-143326246	Active TSS Weak transcription Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
30	rs371248553	chr4:143326265-143326266	Active TSS Weak transcription Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
31	rs375481550	chr4:143326271-143326272	Active TSS Weak transcription Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
32	rs550406883	chr4:143326272-143326273	Active TSS Weak transcription Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
33	rs547598532	chr4:143326274-143326275	Active TSS Weak transcription Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
34	rs554663386	chr4:143326276-143326277	Active TSS Weak transcription Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
35	rs556457345	chr4:143326277-143326278	Active TSS Weak transcription Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
36	rs368527003	chr4:143326278-143326279	Active TSS Weak transcription Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
37	rs571355417	chr4:143326284-143326285	Active TSS Weak transcription Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
38	rs538347736	chr4:143326303-143326304	Active TSS Weak transcription Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
39	rs553780316	chr4:143326304-143326305	Active TSS Weak transcription Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
40	rs150473961	chr4:143326312-143326313	Active TSS Weak transcription Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
41	rs138973882	chr4:143326313-143326314	Active TSS Weak transcription Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
42	rs148852838	chr4:143326315-143326316	Active TSS Weak transcription Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
43	rs138589291	chr4:143326316-143326317	Active TSS Weak transcription Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
44	rs141092086	chr4:143326324-143326325	Active TSS Weak transcription Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
45	rs376711818	chr4:143326326-143326327	Active TSS Weak transcription Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
46	rs67878509	chr4:143326330-143326331	Active TSS Weak transcription Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
47	rs3076598	chr4:143326333-143326334	Active TSS Weak transcription Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
48	rs370644892	chr4:143326384-143326385	Active TSS Weak transcription Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
49	rs374023313	chr4:143326396-143326397	Active TSS Weak transcription Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
50	rs571714237	chr4:143326403-143326404	Active TSS Weak transcription Enhancers Flanking Active TSS Bivalent/Poised TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:75)

Disease	PMID	Source
Acute lymphoblastic leukemia	22237106	CNVD
Glioblastoma multiforme	21080181	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Chordoma	21602918	CNVD
HIV/AIDS	22032296	CNVD
Medulloblastoma	21979893	CNVD
Neuroblastoma	18923191	CNVD
Intellectual disability	22102821	CNVD
Breast cancer	21858162	CNVD
Small bowel adenocarcinoma	21586687	CNVD
Gastric cancer	21586687	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Breast cancer	17603634	CNVD
Esophageal squamous carcinoma	18350619	CNVD
Colorectal cancer	19359472	CNVD
Malignant mesothelioma	18160781	CNVD
Medulloblastoma	18056178	CNVD
Multiple myeloma	17077331	CNVD
Pleural malignant mesothelioma	18160781	CNVD
Primary mediastinal b-cell lymphoma	17728785	CNVD
Oral squamous cell carcinoma	17134496	CNVD
4q-syndrome	17576883	CNVD
Cancer	21637783	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Colorectal cancer	20709793	CNVD
Muscular dystrophy	21149563	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Glioblastoma multiforme	19960244	CNVD
Glioblastoma multiforme	17387387	CNVD
Hepatocellular carcinoma	22174799	CNVD
Liposarcoma	21253554	CNVD
Oligodendroglial tumors	17285580	CNVD
Cervical cancer	21062161	CNVD
Metanephric adenoma	20802469	CNVD
Breast cancer	16608533	CNVD
Lung cancer	19208797	CNVD
Wilms tumour	21544195	CNVD
Breast cancer	21785460	CNVD
Lung cancer	18438408	CNVD
Cancer	22429812	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Cancer	21183584	CNVD
primary effusion lymphomas	17116491	CNVD
Breast cancer	16272173	CNVD
Splenic marginal zone lymphoma	21957467	CNVD
Breast cancer	17133270	CNVD
High-grade prostatic intraepithelial neoplasia	16573809	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Congenital anomalies of the kidney and urinary tract	20505237	CNVD
Breast cancer	17393978	CNVD
Esophageal cancer	21851588	CNVD
Testicular germ cell tumor	18059402	CNVD
Ovarian cancer	22174824	CNVD
Olfactory neuroblastoma	18408657	CNVD
Hodgkin''s lymphoma	18641027	CNVD
Hodgkin''s lymphoma	17606441	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Mental retardation	17901693	CNVD
small cell lung cancer	20016488	CNVD
Developmental delay	21147756	CNVD
T-cell prolymphocytic leukemia	17713554	CNVD
Myelofibrosis	22110671	CNVD
Congenital diaphragmatic hernia	21085971	CNVD
Ewing''s sarcoma	17952124	CNVD
Obesity	20622171	CNVD
Acute lymphoblastic leukemia	21390130	CNVD
Breast cancer	22048815	CNVD
Autism	22241247	CNVD
Glioblastoma multiforme	22286061	CNVD
Renal cell carcinoma	20952505	CNVD
Breast cancer	22522925	CNVD
Pancreatic cancer	17952125	CNVD

Chromatin state (count:529 , 50 per page) page: 1 2 3 4 5 6 7 ... 11

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr4:143300200-143326200	Weak transcription	Aorta	Aorta
2	chr4:143301200-143326200	Weak transcription	Gastric	stomach
3	chr4:143301600-143325400	Weak transcription	Left Ventricle	heart
4	chr4:143313000-143326200	Weak transcription	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
5	chr4:143320600-143326600	Active TSS	Primary T cells fromperipheralblood	blood
6	chr4:143320800-143328000	Active TSS	Foreskin Melanocyte Primary Cells skin01	Skin
7	chr4:143321000-143326800	Active TSS	Primary T cells effector/memory enriched fromperipheralblood	blood
8	chr4:143321400-143326600	Active TSS	Primary T helper memory cells from peripheral blood 2	blood
9	chr4:143321400-143326600	Active TSS	Primary T killer memory cells from peripheral blood	blood
10	chr4:143322000-143326400	Active TSS	Fetal Muscle Leg	muscle
11	chr4:143322200-143326600	Active TSS	Primary T helper naive cells from peripheral blood	blood
12	chr4:143322200-143326600	Active TSS	Primary T helper naive cells fromperipheralblood	blood
13	chr4:143322400-143326400	Weak transcription	ES-UCSF4 Cell Line	embryonic stem cell
14	chr4:143322600-143325400	Enhancers	Cortex derived primary cultured neurospheres	brain
15	chr4:143322600-143326600	Active TSS	Primary T helper cells PMA-I stimulated	--
16	chr4:143322800-143325400	Flanking Active TSS	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
17	chr4:143323000-143325400	Flanking Active TSS	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
18	chr4:143323200-143325400	Enhancers	ES-I3 Cell Line	embryonic stem cell
19	chr4:143323200-143325600	Enhancers	Fetal Heart	heart
20	chr4:143323200-143326600	Active TSS	Rectal Mucosa Donor 29	rectum
21	chr4:143323400-143327200	Weak transcription	Small Intestine	intestine
22	chr4:143323600-143326200	Weak transcription	Ovary	ovary
23	chr4:143323600-143326400	Weak transcription	H9 Cell Line	embryonic stem cell
24	chr4:143323600-143326600	Active TSS	Foreskin Fibroblast Primary Cells skin01	Skin
25	chr4:143323600-143326600	Active TSS	Foreskin Fibroblast Primary Cells skin02	Skin
26	chr4:143323600-143326800	Weak transcription	ES-WA7 Cell Line	embryonic stem cell
27	chr4:143323600-143326800	Active TSS	Foreskin Melanocyte Primary Cells skin03	Skin
28	chr4:143323800-143326600	Active TSS	Primary T killer naive cells fromperipheralblood	blood
29	chr4:143323800-143326800	Active TSS	NHLF	lung
30	chr4:143323800-143327000	Active TSS	Foreskin Keratinocyte Primary Cells skin02	Skin
31	chr4:143324000-143326200	Weak transcription	Brain Germinal Matrix	brain
32	chr4:143324000-143326600	Active TSS	Primary T helper memory cells from peripheral blood 1	blood
33	chr4:143324000-143326800	Active TSS	Psoas Muscle	Psoas
34	chr4:143324200-143325400	Weak transcription	Fetal Muscle Trunk	muscle
35	chr4:143324200-143326000	Flanking Active TSS	Primary hematopoietic stem cells	blood
36	chr4:143324200-143326200	Weak transcription	iPS-15b Cell Line	embryonic stem cell
37	chr4:143324200-143326400	Weak transcription	iPS-20b Cell Line	embryonic stem cell
38	chr4:143324200-143326400	Active TSS	Primary Natural Killer cells fromperipheralblood	blood
39	chr4:143324200-143326600	Weak transcription	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
40	chr4:143324400-143325400	Weak transcription	Brain Hippocampus Middle	brain
41	chr4:143324400-143325400	Weak transcription	Fetal Lung	lung
42	chr4:143324400-143325400	Weak transcription	Right Atrium	heart
43	chr4:143324400-143325600	Weak transcription	Brain Angular Gyrus	brain
44	chr4:143324400-143326000	Weak transcription	HUES6 Cell Line	embryonic stem cell
45	chr4:143324400-143326000	Weak transcription	Fetal Adrenal Gland	Adrenal Gland
46	chr4:143324400-143326200	Weak transcription	HUES48 Cell Line	embryonic stem cell
47	chr4:143324400-143326200	Weak transcription	Brain Dorsolateral Prefrontal Cortex	brain
48	chr4:143324400-143326200	Weak transcription	Brain Substantia Nigra	brain
49	chr4:143324400-143326200	Weak transcription	Pancreas	Pancrea
50	chr4:143324400-143326200	Weak transcription	Rectal Mucosa Donor 31	rectum

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links